Dr. Reddy's Laboratories
246 hedge funds and large institutions have $1.87B invested in Dr. Reddy's Laboratories in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 93 increasing their positions, 86 reducing their positions, and 17 closing their positions.
234% more call options, than puts
Call options by funds: $1.21M | Put options by funds: $362K
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
8% more funds holding
Funds holding: 227 → 246 (+19)
8% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 86
5% more capital invested
Capital invested by funds: $1.79B → $1.87B (+$81.5M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
56.07% less ownership
Funds ownership: 70.28% → 14.21% (-56%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$30.6M |
| 2 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$16.7M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.7M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$16.1M |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$35.7M |
| 2 |
Goldman Sachs
New York
|
-$23.4M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$17.5M |
| 4 |
Man Group
London,
United Kingdom
|
-$13.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$8.49M |
RDY Hedge Fund Activity: Q4 2024 in Review
246 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2024, worth a combined $1.87B — up 4.6% from $1.79B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new RDY positions and 17 closed out — a net gain of 19 holders — while 93 added to existing stakes and 86 trimmed.
The largest buyer was Millennium Management, adding an estimated $30.6M. The largest seller was Bank of America, cutting an estimated $35.7M.
- 246 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2024, up from 227 in Q3 2024.
- Funds reported $1.87B of Dr. Reddy's Laboratories stock for Q4 2024, up 4.6% quarter-over-quarter.
- 36 funds opened new Dr. Reddy's Laboratories positions in Q4 2024 and 17 closed out, a net change of +19 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2024 was Millennium Management, an estimated $30.6M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2024 was Bank of America, an estimated $35.7M sold.
Based on aggregated 13F filings for Q4 2024.